POHCA Resuscitation: Evaluation of IM Epinephrine
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 284 participants.
Also called NCT05166343
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Phase 2/3
- Enrolled
- 284 participants
- Sponsor
- Registry
-
NCT05166343
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05166343. Randomized; no masking; primary purpose supportive care. Start 2024-01-08 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- POHCA Resuscitation: Evaluation of IM Epinephrine
- Acronym
- PRIME
- Condition
- Pediatric Out-of-Hospital Cardiac Arrest
- Intervention (Drug)
- Epinephrine Injection
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Record details
- Record id
cardio:ct-nct05166343- Content hash
4446015987201a8e0a845974d384429c28acad2ee9daf69a13cd6c34478b0945